Kana Watanabe

2.5k total citations
79 papers, 1.2k citations indexed

About

Kana Watanabe is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kana Watanabe has authored 79 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Kana Watanabe's work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Kana Watanabe is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (16 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Kana Watanabe collaborates with scholars based in Japan, Taiwan and United States. Kana Watanabe's co-authors include Makoto Maemondo, Takashi Ishida, Mitsuru Munakata, Toshihiro Nukiwa, Shunichi Sugawara, Jin Murata, Kunihiko Kobayashi, Tatsuro Fukuhara, Yoshinori Ohtsuka and Junpei Saito and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Kana Watanabe

74 papers receiving 1.2k citations

Peers

Countries citing papers authored by Kana Watanabe

Since Specialization

Citations

This map shows the geographic impact of Kana Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kana Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kana Watanabe more than expected).

Fields of papers citing papers by Kana Watanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kana Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kana Watanabe. The network helps show where Kana Watanabe may publish in the future.

Co-authorship network of co-authors of Kana Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Kana Watanabe. A scholar is included among the top collaborators of Kana Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kana Watanabe. Kana Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dissimilar turbulent momentum and heat transfer associated with viscoelastic vibration in channel flow 2023 ·International Journal of Heat and Mass Transfer ·(unknown), Kana Watanabe, (unknown), Takahiro Tsukahara, Yasuo Kawaguchi	2
2	Egg envelope formation of medaka Oryzias latipes requires ZP proteins originating from both the liver and ovary 2023 ·Journal of Biological Chemistry ·(unknown), Kana Watanabe, Shinji Kanda, (unknown), Shigeki Yasumasu, Kaori Sano	6
3	Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M Mutation 2023 ·Cancers ·Kana Watanabe, Ryota Saito, Eisaku Miyauchi, Hiromi Nagashima, Atsushi Nakamura, Shunichi Sugawara, Nobuyuki Tanaka, Hiroshi Terasaki, Tatsuro Fukuhara, Makoto Maemondo	5
4	A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety 2023 ·Biomedicines ·Tatsuro Fukuhara, Kazuhiro Imai, Taku Nakagawa, (unknown), (unknown), Kana Watanabe, Aya Suzuki, Mami Morita, (unknown), Akira Inoue, Masatomo Miura, Yoshihiro Minamiya, Makoto Maemondo	5
5	Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR 2022 ·Journal of Clinical Oncology ·Eisaku Miyauchi, Satoshi Morita, Atsushi Nakamura, Yukio Hosomi, Kana Watanabe, Satoshi Ikeda, Masahiro Seike, Yuka Fujita, Koichi Minato, Ryo Ko, Toshiyuki Harada, Koichi Hagiwara, Kunihiko Kobayashi, Toshihiro Nukiwa, Akira Inoue, (unknown)	53
6	Phase II study of S-1 and irinotecan combination therapy in EGFR-mutated non-small cell lung cancer resistant to epidermal growth factor receptor tyrosine kinase inhibitor: North Japan Lung Cancer Study Group Trial 0804 (NJLCG0804) 2022 ·Medical Oncology ·Atsushi Nakamura, Masao Harada, Kana Watanabe, Toshiyuki Harada, Akira Inoue, Shunichi Sugawara	1
7	Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR‐mutated lung cancer 2021 ·Thoracic Cancer ·(unknown), Hiromi Nagashima, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yoshiaki Mori, Kana Watanabe, Tatsuro Fukuhara, Makoto Maemondo	10
8	Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203 2019 ·Lung Cancer ·Yoko Tsukita, Akira Inoue, Shunichi Sugawara, Shoichi Kuyama, Taku Nakagawa, Daijiro Harada, Hisashi Tanaka, Kana Watanabe, Yoshiaki Mori, Toshiyuki Harada, Toshihiko Hino, Masanori Fujii, Masakazu Ichinose	15
9	Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance 2019 ·EBioMedicine ·Koutaroh Okada, Mitsugu Araki, (unknown), Biao Ma, Ryo Kanada, Noriko Yanagitani, Atsushi Horiike, Sumie Koike, Tomoko Oh‐hara, Kana Watanabe, Keiichi Tamai, Makoto Maemondo, Makoto Nishio, Takeshi Ishikawa, Yasushi Okuno, Naoya Fujita, Ryohei Katayama	87
10	P1.01-08 Randomized Phase II Trial of CBDCA+nab-PTX vs CDDP+GEM in Patients with Chemo-Naïve Squamous Cell Lung Cancer: NJLCG1302 2019 ·Journal of Thoracic Oncology ·Toshiyuki Harada, Yosuke Kawashima, Yasuko Fujita, Taku Nakagawa, Kana Watanabe, Naoto Morikawa, Kei Takamura, Kenya Kanazawa, (unknown), Kazuhiro Usui, Akira Inoue, Akimasa Sekine, Shunichi Sugawara	2
11	P3.02b-113 Clinical Course of NSCLC Patients with EGFR Mutation Undergoing Rebiopsy and Osimertinib Therapy 2017 ·Journal of Thoracic Oncology ·Kenichiro Hirai, Hiroshi Yokouchi, (unknown), Hiroyuki Minemura, Kana Watanabe, Tatsuro Fukuhara, Kenya Kanazawa, Makoto Maemondo, Yoshinori Tanino, Mitsuru Munakata	0
12	Re-biopsy status among non-small cell lung cancer patients in Japan: A retrospective study 2016 ·Lung Cancer ·Kaname Nosaki, Miyako Satouchi, Takayasu Kurata, Tatsuya Yoshida, Isamu Okamoto, Nobuyuki Katakami, Fumio Imamura, Kaoru Tanaka, Yuki Yamane, Nobuyuki Yamamoto, Terufumi Kato, Katsuyuki Kiura, Hideo Saka, Hiroshige Yoshioka, Kana Watanabe, Keiko Mizuno, Takashi Seto	106
13	Total Syntheses of Lactonamycin and Lactonamycin Z with Late‐Stage A‐Ring Formation and Glycosylation 2013 ·Angewandte Chemie International Edition ·Satoshi Adachi, Kana Watanabe, (unknown), (unknown), (unknown), (unknown), (unknown), Yoko Saikawa, Masaya Nakata	39
14	Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Kana Watanabe, Yasunori Yokota, (unknown), Hirohide Nambu, Hideo Yukioka, Norihito Sato, Yukari Tanaka, (unknown), Takayuki Okuno	14
15	Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an anti-obesity profile 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Yuji Nishiura, Kana Watanabe, Nobuyuki Tanaka, Masahiko Fujioka, (unknown), (unknown), Yukari Tanaka, Takeshi Chiba, (unknown), Hirohide Nambu, Hideo Yukioka, Hiroki Sato, Takayuki Okuno	8
16	CAMP (C13orf8, ZNF828) is a novel regulator of kinetochore–microtubule attachment 2010 ·The EMBO Journal ·Go Itoh, Shin‐ichiro Kanno, Kazuhiko Uchida, Shuhei Chiba, (unknown), Kana Watanabe, Kensaku Mizuno, Akira Yasui, Toru Hirota, Kozo Tanaka	47
17	Effects of anesthesia on immunohistochemical detection of phosphorylated extracellular signal-regulated kinase in cerebral cortex 2008 ·Journal of Neuroscience Methods ·Hironori Takamura, Satoshi Ichisaka, Kana Watanabe, (unknown), Yoshio Hata	12
18	Incongruence between DNA-based phylogenies and morphological circumscription in the Aristolochia Kaempferi group 2006 ·Journal of Plant Research ·Kana Watanabe, (unknown), Jin Murata	1
19	Chloroplast DNA variation and geographical structure of the Aristolochia kaempferi group (Aristolochiaceae) 2006 ·American Journal of Botany ·Kana Watanabe, Tadashi Kajita, Jin Murata	31
20	Exhaled nitric oxide as a marker of airway inflammation for an epidemiologic study in schoolchildren 2004 ·Journal of Allergy and Clinical Immunology ·Junpei Saito, Keiichi Inoue, (unknown), (unknown), Kana Watanabe, Takashi Ishida, Yoshinori Ohtsuka, Mitsuru Munakata	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact